Innovent Biologics (HK:1801)
:1801
Advertisement

Innovent Biologics (1801) Similar Stocks

Compare
21 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innovent Biologics
HK$92.25
$148.82B
116.92
156.61%
20 Buy
1 Hold
0 Sell
Strong Buy
Sino Biopharmaceutical
HK$7.34
$124.66B
31.23
124.88%
16 Buy
1 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$33.32
$141.38B
31.20
124.23%
12 Buy
4 Hold
1 Sell
Moderate Buy
Akeso, Inc.
HK$118.80
HK$102.43B
-109.23
72.80%
14 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$25.84
HK$39.42B
-25.19
105.41%
1 Buy
1 Hold
1 Sell
Hold
Shanghai Henlius Biotech, Inc. Class H
HK$67.10
HK$34.13B
38.35
229.73%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1801
Innovent Biologics
92.25
56.30
156.61%
HK:1177
Sino Biopharmaceutical
7.34
4.08
124.88%
HK:2269
Wuxi Biologics (Cayman)
33.32
18.46
124.23%
HK:9926
Akeso, Inc.
118.80
54.90
85.92%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.84
13.26
105.41%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
67.10
46.75
229.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis